0001752724-20-250204.txt : 20201127 0001752724-20-250204.hdr.sgml : 20201127 20201127101439 ACCESSION NUMBER: 0001752724-20-250204 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201127 PERIOD START: 20210630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRUCE FUND INC CENTRAL INDEX KEY: 0000047071 IRS NUMBER: 066104682 STATE OF INCORPORATION: MD FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-01528 FILM NUMBER: 201353289 BUSINESS ADDRESS: STREET 1: 20 N WACKER DR STREET 2: STE 2414 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3122369160 MAIL ADDRESS: STREET 1: 20 N WACKER DR STREET 2: STE 2414 CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: HEROLD FUND INC DATE OF NAME CHANGE: 19831114 0000047071 S000011411 BRUCE FUND C000031584 BRUCE FUND BRUFX NPORT-P 1 primary_doc.xml NPORT-P false 0000047071 XXXXXXXX S000011411 C000031584 Bruce Fund, Inc. 811-01528 0000047071 549300KR3RLFC5M6KA98 20 N. Wacker Dr. Suite 2414 Chicago 45246 312-236-9160 BRUCE FUND S000011411 549300KR3RLFC5M6KA98 2021-06-30 2020-09-30 N 520201989.87 1297704.96 518904284.91 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00 N Ashland Global Holdings Inc 529900E4L9R04SB8HB11 Ashland Global Holdings, Inc. 044186104 25000.00000000 NS USD 1773000.00000000 0.341681510744 Long EC CORP US N 1 N N N Fate Therapeutics 549300L14Q4UHOODLA90 Fate Therapeutics, Inc. 31189P102 100000.00000000 NS USD 3997000.00000000 0.770276930878 Long EC CORP US N 1 N N N Land O'Lakes Capital Trust I N/A Land O'Lakes Capital Trust I 514665AA6 1500000.00000000 PA USD 1710000.00000000 0.329540543357 Long DBT CORP US Y 2 2028-03-15 Fixed 7.45000000 N N N N N N Bunge Limited 5493007M0RIN8HY3MM77 Bunge Ltd. (Bermuda), 4.88% G16962204 27400.00000000 NS USD 2692050.00000000 0.518795099267 Long EP CORP BM N 1 N N N Merck & Co., Inc 4YV9Y5M8S0BRK1RP0397 Merck & Co., Inc. 58933Y105 300000.00000000 NS USD 24885000.00000000 4.795682117814 Long EC CORP US N 1 N N N International Business Machines Corporation VGRQXHF3J8VDLUA7XE92 International Business Machines Corp. 459200101 100000.00000000 NS USD 12167000.00000000 2.344748415810 Long EC CORP US N 1 N N N Novavax Inc 529900J4GJHPEPQ23205 Novavax, Inc. 670002AB0 1000000.00000000 PA USD 1201479.99000000 0.231541736104 Long DBT CORP US N 2 2023-02-01 Fixed 3.75000000 N N N N N Novavax, Inc Novavax, Inc USD XXXX N N N Team Inc 549300DEKHQ3OEQJWU96 Team, Inc. 878155AE0 1000000.00000000 PA USD 840526.53000000 0.161981034738 Long DBT CORP US N 2 2023-08-01 Fixed 5.00000000 N N N N Y Team Inc Team Inc COM USD XXXX N N N Acorda Therapeutic 5493007NPB5YRM8QGL53 Acorda Therapeutics, Inc. 00484MAB2 2500000.00000000 PA USD 1379548.73000000 0.265858033960 Long DBT CORP US Y 2 2024-12-01 Fixed 6.00000000 N N N N Y Acorda Therapeutic Acorda Therapeutic COM USD XXXX N N N Petroquest Energy Inc / Petroquest Energy LLC 5493006TFRWYUQCKTQ17 PetroQuest Energy, Inc. 716748AL2 2629656.00000000 PA USD 262965.60000000 0.050677091642 Long DBT CORP US Y 2 2024-02-15 Fixed 10.00000000 N N Y N N N Xcel Energy Inc LGJNMI9GH8XIDG5RCM61 Xcel Energy, Inc. 98389B100 400000.00000000 NS USD 27604000.00000000 5.319670853130 Long EC CORP US N 1 N N N U.S. Treasury Bond Stripped Principal Payment 254900HROIFWPRGM1V77 U.S. Treasury Strips 912803DQ3 10000000.00000000 PA USD 7802283.50000000 1.503607452644 Long DBT UST US N 2 2041-02-15 None 0.00000000 N N N N N N Petroquest Energy Inc / Petroquest Energy LLC 5493006TFRWYUQCKTQ17 PetroQuest Energy, Inc. 716748405 252248.00000000 NS USD 2522.48000000 0.000486116625 Long EC CORP US N 1 N N N U.S. Treasury Bond Stripped Principal Payment 254900HROIFWPRGM1V77 U.S. Treasury Strips 912803CX9 20000000.00000000 PA USD 17330360.40000000 3.339799054271 Long DBT UST US N 2 2036-02-15 None 0.00000000 N N N N N N U.S. Treasury Bond Stripped Principal Payment 254900HROIFWPRGM1V77 U.S. Treasury Strips 912803CG6 15000000.00000000 PA USD 14257867.95000000 2.747687456940 Long DBT UST US N 2 2029-08-15 None 0.00000000 N N N N N N Chiasma Incorporation 549300PP2WZZEZZ6XS69 Chiasma, Inc. 16706W102 450000.00000000 NS USD 1935000.00000000 0.372901141168 Long EC CORP US N 1 N N N Compass Minerals International Inc. 2549008X9G8XP7YJGC47 Compass Minerals International, Inc. 20451N101 140000.00000000 NS USD 8309000.00000000 1.601258698690 Long EC CORP US N 1 N N N Xtant Medical Holdings Inc 549300JOU6AK8387EW77 Xtant Medical Holdings, Inc. 98420P308 182972.00000000 NS USD 150714.04000000 0.029044670545 Long EC CORP US N 1 N N N Pfizer Inc. 765LHXWGK1KXCLTFYQ30 Pfizer, Inc. 717081103 450000.00000000 NS USD 16515000.00000000 3.182667879272 Long EC CORP US N 1 N N N Abbott Laboratories HQD377W2YR662HK5JX27 Abbott Laboratories 002824100 164500.00000000 NS USD 17902535.00000000 3.450064977417 Long EC CORP US N 1 N N N Security Benefit Life Insurance Company 6GG1425B5X0SPG36P168 Security Benefit Life Insurance Co. 814120AC5 3000000.00000000 PA USD 3405000.00000000 0.656190380195 Long DBT CORP US Y 2 2033-10-01 Fixed 7.45000000 N N N N N N Valvoline Inc 549300CMHPBEY6VPOT75 Valvoline, Inc. 92047W101 68633.00000000 NS USD 1306772.32000000 0.251833017764 Long EC CORP US N 1 N N N Paratek Pharmaceuticals Inc 5493007V5QDIWECEYV79 Paratek Pharmaceuticals 699374AB0 15000000.00000000 PA USD 12330087.90000000 2.376177699542 Long DBT CORP US N 2 2024-05-01 Fixed 4.75000000 N N N N N Paratek Pharmaceuticals Inc Paratek Pharmaceuticals Inc COM USD XXXX N N N Mannkind Corporation 213800GFBCNY1ZFST722 Mannkind Corp. 56400P706 224380.00000000 NS USD 421834.40000000 0.081293296715 Long EC CORP US N 1 N N N Morgan Stanley Institutional Liquidity Funds N/A Morgan Stanley Institutional Liquidity Fund - Government Portfolio 61747C707 28988470.13000000 PA USD 28988470.13000000 5.586477308628 Long STIV RF US N 1 N N N Duke Energy Corp I1BZKREC126H0VB1BL91 Duke Energy Corp. 26441C204 300000.00000000 NS USD 26568000.00000000 5.120019389434 Long EC CORP US N 1 N N N AbbVie Inc. FR5LCKFTG8054YNNRU85 AbbVie, Inc. 00287Y109 228470.00000000 NS USD 20011687.30000000 3.856527664532 Long EC CORP US N 1 N N N Apple Inc. HWUPKR0MPOU8FGXBT394 Apple, Inc. 037833100 260000.00000000 NS USD 30110600.00000000 5.802727184113 Long EC CORP US N 1 N N N Synergy Pharmaceuticals Inc. 549300ITFHW1YXFTGH91 Synergy Pharmaceuticals, Inc. 871639AA8 1500000.00000000 PA USD 150.00000000 0.000028907065 Long DBT CORP US Y 2 2019-11-01 Fixed 7.50000000 N N N N N Synergy Pharmaceuticals, Inc Synergy Pharmaceuticals, Inc USD XXXX N N N Acorda Therapeutic 5493007NPB5YRM8QGL53 Acorda Therapeutics, Inc. 00484MAA4 11000000.00000000 PA USD 6930000.00000000 1.335506412555 Long DBT CORP US N 2 2021-06-15 Fixed 1.75000000 N N N N Y Acorda Therapeutic Acorda Therapeutic COM USD XXXX N N N Supernus Pharmaceuticals, Inc 549300GRM36VBKISYJ58 Supernus Pharmaceuticals, Inc. 868459108 352105.00000000 NS USD 7337868.20000000 1.414108230243 Long EC CORP US N 1 N N N Sirius XM Holdings Inc 54930055RWDMVXAGZK98 Sirius XM Holdings, Inc. 82968B103 1357843.00000000 NS USD 7278038.48000000 1.402578219461 Long EC CORP US N 1 N N N ROCKET PHARMACEUTICALS INC 549300R7VV82YUIN4Y93 Rocket Pharmaceuticals, Inc. 77313FAA4 2000000.00000000 PA USD 2181787.32000000 0.420460455511 Long DBT CORP US N 2 2022-08-01 Fixed 6.25000000 N N N N N ROCKET PHARMACEUTICALS INC ROCKET PHARMACEUTICALS INC COM USD XXXX N N N INDIANAPOLIS IND ARPT AUTH 549300M4VTQEVESQSD44 Indianapolis Airport Authority 455254DA7 972550.92000000 PA USD 291.77000000 0.000056228096 Long DBT MUN US N 2 2031-11-15 Fixed 6.50000000 Y Y N N N N Bausch Health Companies Inc B3BS7ACMDUWISF18KY76 Bausch Health Cos, Inc. 071734107 1250000.00000000 NS USD 19425000.00000000 3.743464944285 Long EC CORP CA N 1 N N N Nextera Energy Inc N/A NextEra Energy, Inc. 65339F101 135000.00000000 NS USD 37470600.00000000 7.221100516928 Long EC CORP US N 1 N N N Avista Corporation Q0IK63NITJD6RJ47SW96 Avista Corp. 05379B107 200000.00000000 NS USD 6824000.00000000 1.315078753142 Long EC CORP US N 1 N N N U.S. Treasury Bond Stripped Principal Payment 254900HROIFWPRGM1V77 United States Treasury Strip Principal 912803FJ7 30000000.00000000 PA USD 19558094.40000000 3.769114067615 Long DBT UST US N 2 2049-05-15 None 0.00000000 N N N N N N Paratek Pharmaceuticals Inc 5493007V5QDIWECEYV79 Paratek Pharmaceuticals, Inc. 699374302 879312.00000000 NS USD 4757077.92000000 0.916754410849 Long EC CORP US N 1 N N N Newmont Corporation 549300VSP3RIX7FGDZ51 Newmont Goldcorp Corp. 651639106 65600.00000000 NS USD 4162320.00000000 0.802136371011 Long EC CORP US N 1 N N N N/A N/A Aspire Holdings, LLC. N/A 193069.00000000 NS USD 0.00000000 0.000000 Long EC CORP US Y 1 N N N CMS Energy Corporation 549300IA9XFBAGNIBW29 CMS Energy Corp. 125896100 450000.00000000 NS USD 27634500.00000000 5.325548623055 Long EC CORP US N 1 N N N General Electric Company 3C7474T6CDKPR9K6YT90 General Electric Co. 369604103 1000000.00000000 NS USD 6230000.00000000 1.200606774923 Long EC CORP US N 1 N N N N/A N/A Mannkind Corp. N/A 2630750.00000000 PA USD 2630750.00000000 0.506981745285 Long DBT CORP US Y 2 N N N The Allstate Corporation OBT0W1ED8G0NWVOLOJ77 Allstate Corp. 020002101 275000.00000000 NS USD 25888500.00000000 4.989070384047 Long EC CORP US N 1 N N N Flotek Industries, Inc. 549300TF60OEK4FPPC44 Flotek Industries, Inc. 343389102 390671.00000000 NS USD 1058718.41000000 0.204029614090 Long EC CORP US N 1 N N N N/A N/A MannKind Corp. N/A 5000000.00000000 PA USD 3750000.00000000 0.722676630170 Long DBT CORP US Y 3 N N N Actua Corporation 549300Z58VWYRMOUS305 Actua Corp. 005094107 130000.00000000 NS USD 6500.00000000 0.001252639492 Long EC CORP US N 1 N N N Edap Tms Sa N/A EDAP TMS SA 268311107 733094.00000000 NS USD 3372232.40000000 0.649875612529 Long EC CORP FR N 1 N N N Chevron Corporation N/A Chevron Corp. 166764100 50000.00000000 NS USD 3600000.00000000 0.693769564964 Long EC CORP US N 1 N N N Prothena Corp Plc 5299009ZXQ8NIIJ8OL30 Prothena Corp. PLC G72800108 3170.00000000 NS USD 31668.30000000 0.006102917420 Long EC CORP IE N 1 N N N Amerco 5493003WIDMLDHYC6Y24 AMERCO 023586100 120167.00000000 NS USD 42777048.66000000 8.243726233137 Long EC CORP US N 1 N N N 2020-11-09 Bruce Fund, Inc. Gregory Knoth Gregory Knoth VP, Mutual Fund Controller XXXX NPORT-EX 2 fp0058662_nportex.htm BRUCE EX-FILE
BRUCE FUND
SCHEDULE OF INVESTMENTS
September 30, 2020 (Unaudited)

 

COMMON STOCKS — 75.5%  Shares   Fair Value 
Communications — 1.4%
Actua Corp.(a)(b)(c)   130,000   $6,500 
Sirius XM Holdings, Inc.   1,357,843    7,278,038 
         7,284,538 
Energy — 0.9%
Aspire Holdings, LLC(a)(b)(c)   193,069     
Chevron Corp.   50,000    3,600,001 
Flotek Industries, Inc.(c)   390,671    1,058,718 
PetroQuest Energy, Inc.(a)(b)(c)   252,248    2,522 
         4,661,241 
Financials — 5.0%
Allstate Corp.   275,000    25,888,500 
           
Health Care — 23.3%
Abbott Laboratories   164,500    17,902,535 
AbbVie, Inc.   228,470    20,011,687 
Bausch Health Cos., Inc. (Canada)(c)   1,250,000    19,425,001 
Chiasma, Inc.(c)   450,000    1,935,000 
EDAP TMS SA - ADR (France)(c)   733,094    3,372,232 
Fate Therapeutics, Inc.(c)   100,000    3,997,000 
MannKind Corp.(c)   224,380    421,834 
Merck & Co., Inc.   300,000    24,885,001 
Paratek Pharmaceuticals, Inc.(c)   879,312    4,757,078 
Pfizer, Inc.   450,000    16,515,000 
Prothena Corporation PLC (Ireland)(c)   3,170    31,668 
Supernus Pharmaceuticals, Inc.(c)   352,105    7,337,868 
Xtant Medical Holdings, Inc.(c)   182,972    150,714 
         120,742,618 
Industrials — 9.4%
AMERCO   120,167    42,777,049 
General Electric Co.   1,000,000    6,230,000 
         49,007,049 
Materials — 3.0%
Ashland Global Holdings, Inc.   25,000    1,773,000 
Compass Minerals International, Inc.   140,000    8,309,000 
Newmont Goldcorp Corp.   65,600    4,162,320 
Valvoline, Inc.   68,633    1,306,772 
         15,551,092 
Technology — 8.2%
Apple, Inc.   260,000    30,110,600 
International Business Machines Corp.   100,000    12,167,000 
         42,277,600 
Utilities — 24.3%
Avista Corp.   200,000    6,824,000 
CMS Energy Corp.   450,000    27,634,500 
Duke Energy Corp.   300,000    26,568,000 
NextEra Energy, Inc.   135,000    37,470,600 

 

 

 

  

Shares/

Principal

Amount

   Fair Value 
Xcel Energy, Inc.   400,000   $27,604,000 
         126,101,100 
Total Common Stocks (Cost $226,602,695)        391,513,738 
           
CONVERTIBLE PREFERRED STOCKS — 0.5%          
Consumer Staples — 0.5%
Bunge Ltd. (Bermuda), 4.88%   27,400    2,692,050 
Total Convertible Preferred Stocks (Cost $2,864,600)        2,692,050 
           
U.S. GOVERNMENT BONDS — 11.4%          
U.S. Treasury "Strips", 0.00%, 8/15/2029  $15,000,000    14,257,868 
U.S. Treasury "Strips", 0.00%, 2/15/2036   20,000,000    17,330,360 
U.S. Treasury "Strips", 0.00%, 2/15/2041   10,000,000    7,802,284 
U.S. Treasury "Strips", 0.00%, 5/15/2049   30,000,000    19,558,094 
Total U.S. Government Bonds (Cost $41,103,967)        58,948,606 
           
CONVERTIBLE CORPORATE BONDS — 5.5%          
Health Care — 5.3%          
Acorda Therapeutics, Inc., 1.75%, 6/15/2021   11,000,000    6,930,000 
Acorda Therapeutics, Inc., 6.00%, 12/1/2024   2,500,000    1,379,549 
MannKind Corp., 5.75%, 10/23/2024(a)(b)   5,000,000    3,750,000 
Novavax, Inc., 3.75%, 2/1/2023   1,000,000    1,201,480 
Paratek Pharmaceuticals, Inc., 4.75%, 5/1/2024   15,000,000    12,330,087 
Rocket Pharmaceuticals, Inc., 6.25%, 8/1/2022   2,000,000    2,181,787 
Synergy Pharmaceuticals, Inc., 7.50%, 11/1/2019(a)(b)(d)(e)   1,500,000    150 
         27,773,053 
Industrials — 0.2%          
Team, Inc., 5.00%, 8/1/2023(d)   1,000,000    840,527 
Total Convertible Corporate Bonds (Cost $36,027,448)        28,613,580 
           
CORPORATE BONDS — 1.5%          
Consumer Staples — 0.3%          
Land O'Lakes Capital Trust I, 7.45%, 3/15/2028(d)   1,500,000    1,710,000 
           
Energy — 0.1%          
PetroQuest Energy, Inc., 10.00%, 2/15/2024(a)(b)(e)(f)   2,629,656    262,966 
           
Financials — 0.6%          
Security Benefit Life Insurance Co., 7.45%, 10/1/2033(d)   3,000,000    3,405,000 
           
Health Care — 0.5%          
MannKind Corp., 0.00%, 12/30/2020(a)(b)   2,630,750    2,630,750 
Total Corporate Bonds (Cost $9,194,236)        8,008,716 

 

 

 

  

Shares/

Principal

Amount

   Fair Value 
U.S. MUNICIPAL BONDS — 0.0%          
Indianapolis Airport Authority, 6.50%, 11/15/2031(b)(c)(e)  $972,551   $292 
Total U.S. Municipal Bonds (Cost $162,383)        292 
           
MONEY MARKET FUNDS - 5.6%          
Morgan Stanley Institutional Liquidity Government Portfolio, Institutional Class, 0.02%(g)   28,988,470    28,988,470 
Total Money Market Funds (Cost $28,988,470)        28,988,470 
           
Total Investments — 100.0% (Cost $344,943,799)        518,765,452 
Liabilities in Excess of Other Assets — 0.0%        (54,393)
NET ASSETS — 100.0%       $518,711,059 

 

(a) Security is currently being valued according to the fair value procedures approved by the Board of Directors.
(b) Illiquid security. The total fair value of these securities as of September 30, 2020 was $6,653,180, representing 1.3% of net assets.
(c) Non-income producing security.
(d) Security exempt from registration under Rule 144A or Section 4(2) of the Securities Act of 1933. The security may be resold in transactions exempt from registration, normally to qualified institutional buyers. The total fair value of these securities as September 30, 2020 was $5,955,677, representing 1.1% of net assets.
(e) In default.
(f) Payment in kind security which may pay interest in additional principal.
(g) Rate disclosed is the seven day effective yield as of September 30, 2020.

 

ADR - American Depositary Receipt

 

See accompanying notes which are an integral part of this schedule of investments.

 

At September 30, 2020, the breakdown of net unrealized appreciation and tax cost of investments for federal income tax purpose is as follows:

 

Gross Unrealized Appreciation  $197,118,377 
Gross Unrealized Depreciation   (23,996,575)
Net Unrealized Appreciation on Investments  $173,121,802 
Tax Cost  $345,643,650 

 

 

 

BRUCE FUND, INC.

NOTES TO THE SCHEDULE OF INVESTMENTS

September 30, 2020 (Unaudited)

The Bruce Fund (the “Fund”) is an investment company and follows accounting and reporting guidance under Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946, “Financial Services-Investment Companies”. The following is a summary of significant accounting policies consistently followed by the Fund in the preparation of its financial statements. The policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Security Transactions and Related Income – Investment transactions are accounted for no later than the first calculation of the Net Asset Value (“NAV”) on the business day following the trade date. For financial reporting purposes, however, security transactions are accounted for on the trade date on the last business day of the reporting period. The specific identification method is used for determining gains or losses for financial statements and income tax purposes. Dividend income is recorded on the ex-dividend date and interest income is recorded on an accrual basis. Discounts and premiums on securities purchased are accreted or amortized using the effective interest method. Withholding taxes on foreign dividends have been provided for in accordance with the Fund’s understanding of the applicable country’s tax rules and rates. The ability of issuers of debt securities held by the Fund to meet their obligations may be affected by economic and political development in specific country or region.

 

Securities Valuation and Fair Value Measurements – In accordance with Accounting Standards Codification 820, “Fair Value Measurements and Disclosures” (“ASC 820”), fair value is defined as the price that the Fund would receive upon selling an investment in an orderly transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of the observable market data and minimize the use of unobservable inputs and to establish classification of the fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk (the risk inherent in a particular valuation technique used to measure fair value such as pricing model and/or the risk inherent in the inputs to the valuation technique). Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability, developed based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad levels listed below:

 

·Level 1 – unadjusted quoted prices in active markets for identical investments and/or registered investment companies where the value per share is determined and published and is the basis for current transactions for identical assets or liabilities at the valuation date

 

·Level 2 – other significant observable inputs (including, but not limited to, quoted prices for an identical security in an inactive market, quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)

 

·Level 3 – significant unobservable inputs (including the Fund’s own assumptions in determining fair value of investments based on the best information available)

The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

 

Equity securities, including common stocks, convertible preferred stocks, and American Depositary Receipts (ADR’s), are generally valued by using market quotations, but may be valued on the basis of prices furnished by a pricing service when the Adviser believes such prices more accurately reflect the fair value of such securities. Securities that are traded on any stock exchange are generally valued by the pricing service at the last quoted sale price. Lacking a last sale price, an exchange traded security is generally valued by the pricing service at its last bid price. Securities traded in the NASDAQ over-the-counter market are generally valued by the pricing service at the NASDAQ Official Closing Price. When using the market quotations or close prices provided by the pricing service and when the market is considered active, the security will be classified as a Level 1 security. Sometimes, an equity security owned by the Fund will be valued by the pricing service with factors other than market quotations or when the market is considered inactive. When this happens, the security will be classified as a Level 2 security.

 

 

 

BRUCE FUND, INC.

NOTES TO THE SCHEDULE OF INVESTMENTS - continued

September 30, 2020 (Unaudited)

 

When market quotations are not readily available, when the Adviser determines that the market quotation or the price provided by the pricing service does not accurately reflect the current fair value, or when restricted or illiquid securities are being valued, such securities are valued as determined by the Adviser, in conformity with guidelines adopted by and subject to review by the Board of Directors (the “Board”). These securities are generally categorized as Level 3 securities.

 

Investments in mutual funds, including money market mutual funds, are generally priced at the ending NAV provided by the service agent of the funds. These securities will be categorized as Level 1 securities.

 

Fixed income securities, including corporate bonds, convertible corporate bonds, U.S. government bonds, and U.S. municipal bonds are generally categorized as Level 2 securities and valued on the basis of prices furnished by a pricing service. A pricing service uses various inputs and techniques, which include broker-dealer quotations, live trading levels, recently executed transactions in securities of the issuer or comparable issuers, and option adjusted spread models that include base curve and spread curve inputs. Adjustments to individual bonds can be applied to recognize trading differences compared to other bonds issued by the same issuer. The broker-dealer quotations received are supported by credit analysis of the issuer that takes into consideration credit quality assessments, daily trading activity, and the activity of the underlying equities, listed bonds and sector-specific trends. To the extent that these inputs are observable, the fixed income securities are categorized as Level 2 securities. If the Adviser decides that a price provided by the pricing service does not accurately reflect the fair value of the securities, when prices are not readily available from a pricing service, or when restricted or illiquid securities are being valued, securities are valued at fair value as determined in good faith by the Adviser, in conformity with guidelines adopted by and subject to review of the Board. These securities are generally categorized as Level 3 securities.

 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2020 based on the three levels defined previously:

 

   Level 1  Level 2  Level 3  Total
Common Stocks                    
Communications  $7,278,038   $-   $6,500   $7,284,538 
Energy   4,658,719    -    2,522    4,661,241 
Financials   25,888,500    -    -    25,888,500 
Health Care   120,742,618    -    -    120,742,618 
Industrials   49,007,049    -    -    49,007,049 
Materials   15,551,092    -    -    15,551,092 
Technology   42,277,600    -    -    42,277,600 
Utilities   126,101,100    -    -    126,101,100 
Convertible Preferred Stocks                    
Consumer Staples   2,692,050    -    -    2,692,050 
U.S. Government Bonds                    
U.S. Treasury Strips   -    58,948,606    -    58,948,606 
Convertible Corporate Bonds                    
Health Care   -    24,022,903    3,750,150    27,773,053 
Industrials   -    840,527    -    840,527 
Corporate Bonds                    
Consumer Staples   -    1,710,000    -    1,710,000 
Energy   -    -    262,966    262,966 
Financials   -    3,405,000    -    3,405,000 
Health Care   -    -    2,630,750    2,630,750 
U.S. Municipal Bonds   -    292    -    292 
Money Market Funds   28,988,470    -    -    28,988,470 
Total  $423,185,236   $88,927,328   $6,652,888   $518,765,452 

 

 

 

BRUCE FUND, INC.

NOTES TO THE SCHEDULE OF INVESTMENTS - continued

September 30, 2020 (Unaudited)

 

In the absence of a listed price quote, or a supplied price quote which is deemed to be unrepresentative of the actual market price, the Adviser shall use any or all of the following criteria to value Level 3 securities:

 

·Last sales price
·Price given by pricing service
·Last quoted bid & asked price
·Third party bid & asked price
·Indicated opening range

 

The significant unobservable inputs that may be used in the fair value measurement of the Fund’s investments in common stock, corporate bonds and convertible corporate bonds for which market quotations are not readily available include: broker quotes, discounts from the most recent trade or “stale price” and estimates from trustees (in bankruptcies) on disbursements. A change in the assumption used for each of the inputs listed above may indicate a directionally similar change in the fair value of the investment.

The following provides quantitative information about the Fund’s significant Level 3 fair value measurements as of September 30, 2020:

 

Quantitative Information about Significant Level 3 Fair Value Measurements
Asset Category  Fair Value At
September 30, 2020
  Valuation Techniques  Unobservable Input(s)  Range
Common Stocks  $2,522   Adjusted Broker Quotes  Non-Binding Broker Quotes   N/A 
    6,500   Asset Liquidation Analysis  Liquidation Proceeds   N/A 
                 
Convertible Corporate Bonds   3,750,150   Adjusted Broker Quotes  Non-Binding Broker Quotes   N/A 
           Discount for Lack of Marketability   1%-20% 
                 
        Comparable Security Analysis  Matrix Pricing Range   N/A 
           Common Stock Valuation   N/A 
                 
Corporate Bonds   2,893,716   Price at Par  Liquidation/ Reorganization Valuation   50%-100% 

 

Following is a reconciliation of assets in which significant unobservable inputs (Level 3) were used in determining fair value for the Fund:

 

   Balance as of June 30, 2020  Realized gain (loss)    Amortization/Accretion    Change in unrealized appreciation (depreciation)
Common Stock  $10,953   $-    $-    $(1,931)
Convertible Corporate Bonds   3,750,150    -     -     - 
Corporate Bonds   2,881,194    -     -     (112,700)
  Total  $6,642,297   $-    $-    $(114,631)

 

Purchases    Sales    Transfer in Level 3* (a)    Transfer out Level 3* (b)    Balance as of
September 30, 2020
$-    $-    $-    $-    $9,022 
 -     -     -     -     3,750,150 
 125,222     -     -     -     2,893,716 
$125,222    $-    $-    $-    $6,652,888 

 

 

 

BRUCE FUND, INC.

NOTES TO THE SCHEDULE OF INVESTMENTS - continued

September 30, 2020 (Unaudited)

 

*The amount of transfers in and/or out are reflected at the reporting period end.

 

(a)Transfers in relate primarily to securities for which observable inputs became unavailable during the period. Therefore, the securities were valued at fair value by the Adviser, in conformity with guidelines adopted by and subject to review by the Board, and are categorized as Level 3 inputs as of September 30, 2020.

 

(b)Transfers out relate primarily to securities for which observable inputs became available during the period, and as of September 30, 2020, the Fund was able to obtain quotes from its pricing service. These quotes represent Level 2 inputs, which is the level of the fair value hierarchy in which these securities are included as of September 30, 2020.

 

The total change in unrealized appreciation attributable to Level 3 investments still held at September 30, 2020 was as follows:

  

Total Change in

Unrealized Appreciation (Depreciation)

Common Stock  $(1,931)
Convertible Corporate Bonds   - 
Corporate Bonds   (112,700)
Total  $(114,631)

 

Restricted Securities – The Fund has acquired several securities, the sale of which is restricted, through private placement. At September 30, 2020, the aggregate market value of such securities listed below amounted to $5,955,677 or 1.1% of the Fund’s net assets. 100% of the restricted securities are valued using quoted market prices, while the other 0.0% are valued according to fair value procedures approved by the Board. It is possible that the estimated value may differ significantly from the amount that might ultimately be realized in the near term, and the difference could be material.

 

The chart below shows the restricted securities held by the Fund as of September 30, 2020:

 

Issuer Description  Acquisition Date  Principal Amount  Cost  Value
Corporate Bonds                  
Land O' Lakes Capital Trust I, 7.45%, 3/15/28  1/23/09  $1,500,000   $1,144,534   $1,710,000 
Security Benefit Life Insurance Co., 7.45%, 10/1/33  (a)   3,000,000    2,789,293    3,405,000 
                   
Convertible Corporate Bonds                  
Synergy Pharmaceuticals, Inc., 7.50%, 11/1/19  3/4/15   1,500,000    932,534    150 
Team, Inc., 5.00%, 8/1/23  8/24/17   1,000,000    931,865    840,527 

 

(a) Purchased multiple taxlots beginning on 4/21/11.